BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27773614)

  • 1. Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.
    Goutté N; Sogni P; Bendersky N; Barbare JC; Falissard B; Farges O
    J Hepatol; 2017 Mar; 66(3):537-544. PubMed ID: 27773614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Costentin CE; Sogni P; Falissard B; Barbare JC; Bendersky N; Farges O; Goutte N
    Dig Dis Sci; 2020 Jan; 65(1):301-311. PubMed ID: 31346950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.
    Clark PJ; Stuart KA; Leggett BA; Crawford DH; Boyd P; Fawcett J; Whiteman DC; Baade PD
    Liver Int; 2015 Dec; 35(12):2584-94. PubMed ID: 25900432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcomes of treating of hepatocellular carcinoma among Medicare recipients in the United States: a population-based study.
    El-Serag HB; Siegel AB; Davila JA; Shaib YH; Cayton-Woody M; McBride R; McGlynn KA
    J Hepatol; 2006 Jan; 44(1):158-66. PubMed ID: 16290309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma in Australia 1982-2014: Increasing incidence and improving survival.
    Wallace MC; Preen DB; Short MW; Adams LA; Jeffrey GP
    Liver Int; 2019 Mar; 39(3):522-530. PubMed ID: 30230194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?
    Edenvik P; Davidsdottir L; Oksanen A; Isaksson B; Hultcrantz R; Stål P
    Liver Int; 2015 Jul; 35(7):1862-71. PubMed ID: 25524812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC Registry.
    Weinmann A; Koch S; Niederle IM; Schulze-Bergkamen H; König J; Hoppe-Lotichius M; Hansen T; Pitton MB; Düber C; Otto G; Schuchmann M; Galle PR; Wörns MA
    J Clin Gastroenterol; 2014 Mar; 48(3):279-89. PubMed ID: 24045276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiological trends of hepatocellular carcinoma in Austria.
    Pinter M; Hucke F; Zielonke N; Trauner M; Sieghart W; Peck-Radosavljevic M
    Dig Dis; 2014; 32(6):664-9. PubMed ID: 25376282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving prognosis for patients with hepatocellular carcinoma in Ireland 1994-2008.
    Gaynor C; Iqbal M; Comber H; Deady S; McCormick PA
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):221-224. PubMed ID: 27832038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-trends in incidence and prognosis of hepatocellular carcinoma in Denmark: A nationwide register-based cohort study.
    Jepsen P; Andersen MW; Villadsen GE; Ott P; Vilstrup H
    Liver Int; 2017 Jun; 37(6):871-878. PubMed ID: 27943604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and prognosis of hepatocellular carcinoma: a population based study in France.
    Borie F; Bouvier AM; Herrero A; Faivre J; Launoy G; Delafosse P; Velten M; Buemi A; Peng J; Grosclaude P; Trétarre B
    J Surg Oncol; 2008 Dec; 98(7):505-9. PubMed ID: 18932235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
    Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
    World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma in a low-endemic area: rising incidence and improved survival.
    Witjes CD; Karim-Kos HE; Visser O; van den Akker SA; de Vries E; Ijzermans JN; de Man RA; Coebergh JW; Verhoef C
    Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):450-7. PubMed ID: 22273986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based study.
    El-Serag HB; Davila JA
    Hepatology; 2004 Mar; 39(3):798-803. PubMed ID: 14999699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new prognostic score can predict survival after hepatocellular carcinoma treatment in a cohort of 1302 Egyptian hepatocellular carcinoma patients.
    Abdelaziz AO; Shousha HI; Abdelmaksoud AH; Saad Y; Elbaz TM; Soliman ZA; Salah A; Lithy R; Ahmed M; Nabil MM
    Eur J Gastroenterol Hepatol; 2018 May; 30(5):514-519. PubMed ID: 29465472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of hepatocellular carcinoma patients is significantly improving: a population-based study from southern Switzerland.
    Bordoni A; Cerny A; Bihl F; Alerci M; Mazzola P; Peverelli S; Marini G; Majno P; Mazzucchelli L; Spitale A
    Cancer Epidemiol; 2014 Dec; 38(6):679-85. PubMed ID: 25454980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Childhood liver tumors in Argentina: Incidence trend and survival by treatment center. A report from the national pediatric cancer registry, ROHA network 2000-2015.
    Moreno F; Rose A; Chaplin MA; Cipolla MC; García Lombardi M; Nana M; Cervio G; Halac E; Viso M; Ayarzabal V; Bosaleh A; Liberto D; Sarabia E; Rizzi A; Morici M; Streitenberger P; de Dávila MTG
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28583. PubMed ID: 32737960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rising incidence of hepatitis B-related hepatocellular carcinoma in South Australia: 1996-2010.
    Chinnaratha MA; Graham C; Fraser RJ; Woodman RJ; Wigg AJ
    Intern Med J; 2016 Aug; 46(8):902-8. PubMed ID: 27130077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.